SCHEMBL17083878

SCHEMBL17083878

CCCCCC[C@H](CCCCCCCCCCC(=O)Oc1ccc(N=C=O)cc1)OC(=O)COCC(=O)Oc1ccc(OC#N)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MEN1 O00255 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SLC22A2 O15244 1/20 0.33
▸ TMPRSS2 O15393 1/20 0.33
▸ F2 P00734 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ PLG P00747 1/20 0.33
▸ F12 P00748 1/20 0.33
▸ PLAU P00749 1/20 0.33
▸ PLAT P00750 1/20 0.33
▸ KLKB1 P03952 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HPN P05981 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17086055 0.94 KMT2A (0.41) KMT2ASMN1; SMN2MEN1NPC1RAB9A
SCHEMBL17083873 0.93 KMT2A (0.39) KMT2ASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL17083876 0.92 TRPV1 (0.37) KMT2ASMN1; SMN2MAPTCNR2ALDH1A1
SCHEMBL17083849 0.88 KMT2A (0.39) KMT2ASMN1; SMN2MEN1NPC1RAB9A
SCHEMBL17083871 0.88 KMT2A (0.39) KMT2ASMN1; SMN2MEN1NPC1RAB9A
SCHEMBL17083830 0.88 ALDH1A1 (0.34) KMT2AMEN1CNR2ALDH1A1LMNA
SCHEMBL17083810 0.87 TLR2 (0.37) CNR2ALDH1A1LMNA
SCHEMBL17083861 0.86 KMT2A (0.38) KMT2ASMN1; SMN2MEN1NPC1RAB9A
SCHEMBL17086056 0.86 KMT2A (0.44) KMT2ASMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL17083869 0.85 PRKCA (0.39) KMT2ASMN1; SMN2MAPTCNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9328192-B2 Bio-based monomers and polymers BEZWADA BIOMEDICAL, LLC (US) 2016-05-03 — — US disclosed
US-20150259464-A1 BIO-BASED MONOMERS AND POLYMERS BEZWADA BIOMEDICAL, LLC 2015-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259464-A1 BIO-BASED MONOMERS AND POLYMERS FHIT, MGAM, BPGM KMT2A 4052/4885SMN1; SMN2 4223/4885MEN1 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback